Stocktoria
NATURAL HEALTH TRENDS CORP NHTC
NATURAL HEALTH TRENDS CORP financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $39.8M | $43.0M | $43.9M | $49.1M | $60.0M | $62.1M | $77.6M | $191.9M | $197.6M | — |
| Gross profit | $29.3M | $31.8M | $32.7M | $36.5M | $45.0M | $45.1M | $57.5M | $152.5M | $158.9M | $232.8M |
| SG&A expense | $14.8M | $15.5M | $16.0M | $16.0M | $17.8M | $18.2M | $27.2M | $31.3M | $32.2M | $43.2M |
| Operating income | -$1.8M | -$1.3M | -$1.7M | -$270,000 | $1.6M | $669,000 | -$7.0M | $33.7M | $43.1M | $64.1M |
| Income tax | $315,000 | $48,000 | $177,000 | $289,000 | $425,000 | $647,000 | $14,000 | $3.5M | $19.8M | $9.0M |
| Net income | -$882,000 | $572,000 | $568,000 | $313,000 | $1.1M | $843,000 | -$5.6M | $31.0M | $23.6M | $55.1M |
| EPS (diluted) | $-0.08 | $0.05 | $0.05 | $0.03 | $0.09 | $0.07 | $-0.52 | $2.74 | $2.09 | $4.83 |
| Operating cash flow | -$6.0M | -$3.4M | -$4.3M | -$4.9M | $1.0M | $1.9M | -$18.6M | $29.7M | $26.6M | $53.2M |
| Free cash flow | -$6.1M | -$3.4M | -$4.3M | -$5.0M | $791,000 | $1.7M | -$18.8M | $29.5M | $26.3M | $52.3M |
| Cash & equivalents | $6.8M | $13.5M | $56.2M | $69.7M | $83.8M | $92.4M | $96.0M | $132.7M | $135.3M | $125.9M |
| Inventory | $2.0M | $3.3M | $4.3M | $4.5M | $5.3M | $3.8M | $6.4M | $12.2M | $8.4M | $11.3M |
| Total assets | $38.4M | $55.4M | $69.1M | $82.8M | $98.4M | $105.9M | $118.5M | $157.9M | $159.6M | $148.1M |
| Total liabilities | $15.0M | $22.5M | $27.5M | $32.7M | $38.9M | $38.2M | $43.4M | $68.1M | $68.9M | $65.6M |
| Shareholders' equity | $23.4M | $32.9M | $41.6M | $50.2M | $59.5M | $67.7M | $75.1M | $89.9M | $90.6M | $82.4M |
Growth · year-over-year · Revenue CAGR -18.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -7.4% | -2.2% | -10.6% | -18.1% | -3.3% | -20.0% | -59.6% | -2.9% | — | — |
| Net income growth | -254.2% | +0.7% | +81.5% | -71.2% | +28.7% | — | -118.1% | +31.6% | -57.2% | +16.6% |
| EPS growth | -260.0% | +0.0% | +66.7% | -66.7% | +28.6% | — | -119.0% | +31.1% | -56.7% | +26.4% |
| Free cash flow growth | — | — | — | -731.5% | -52.7% | — | -163.8% | +12.0% | -49.6% | -35.2% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.